Tag: Johnson & Johnson

Novavax: It’s the vaccine that scares antivaxxers, not moth DNA or any ingredient in any vaccine

The Novavax COVID-19 vaccine was recently granted emergency use approval by the FDA. Company executives and some public health officials have expressed hope that this recombinant protein-based vaccine will be more palatable to the vaccine-hesitant than existing vaccines using new (and therefore scarier) mRNA and adenovirus platforms. The reaction to the use of moth cells to produce the Novavax vaccine shows that...